Glenmark Life Sciences’ IPO | Core Strengths & Key Risks Explained

Glenmark’s API subsidiary Glenmark Life Sciences’ IPO process will commence this week.

IPO DETAILS:
Subscription: 27-29 July
Price band: Rs 695-720 per share
Total issue size: `1513.6 cr
Use of proceeds:
- Payment of outstanding purchase consideration to Promoter for the spin-off of API business (from Promoter into their company)
- Funding working capital requirements
- General corporate purposes

Ahead of the IPO, Moneycontrol's Karunya Rao fills us in on all the details to help you decide if you should subscribe to offer or not.

https://www.moneycontrol.com/news/business/ipo/glenmark-life-sciences-ipo-core-strengths-key-risks-explained-7225711.html

#GlenmarkLifeSciences #IPO

Follow us:
Website: https://www.moneycontrol.com/
Facebook: https://www.facebook.com/moneycontrol/
Twitter: http://www.twitter.com/moneycontrolcom
Instagram: https://www.instagram.com/moneycontrolcom/

stock market tipsstocksmoneycontrolMoneycontrol news